Ceridian HCM Holding Inc (NYSE:CDAY) – Stock analysts at Mitsubishi UFJ Financial Group cut their FY2018 earnings estimates for shares of Ceridian HCM in a research note issued to investors on Monday, October 29th, Zacks Investment Research reports. Mitsubishi UFJ Financial Group analyst S. Bersey now expects that the company will post earnings per share of ($0.58) for the year, down from their prior estimate of ($0.55). Mitsubishi UFJ Financial Group also issued estimates for Ceridian HCM’s Q4 2018 earnings at $0.07 EPS, Q1 2019 earnings at $0.11 EPS, Q2 2019 earnings at $0.05 EPS, Q3 2019 earnings at $0.07 EPS, Q4 2019 earnings at $0.06 EPS and FY2019 earnings at $0.29 EPS.
Ceridian HCM (NYSE:CDAY) last released its quarterly earnings data on Monday, October 29th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. Ceridian HCM had a negative net margin of 2.25% and a positive return on equity of 2.64%. The business had revenue of $179.60 million during the quarter, compared to analyst estimates of $176.29 million. The firm’s quarterly revenue was up 9.8% compared to the same quarter last year.
A number of other research analysts have also commented on CDAY. William Blair upgraded shares of Ceridian HCM from a “market perform” rating to an “outperform” rating in a research report on Friday, August 10th. Citigroup reduced their price target on shares of Ceridian HCM from $38.00 to $35.00 and set a “neutral” rating for the company in a research report on Friday, August 10th. Canaccord Genuity restated a “hold” rating and set a $36.00 price target on shares of Ceridian HCM in a research report on Friday, August 10th. Guggenheim started coverage on shares of Ceridian HCM in a research report on Monday, August 20th. They set a “buy” rating and a $45.00 price target for the company. Finally, Barclays boosted their price target on shares of Ceridian HCM from $35.00 to $36.00 and gave the company an “equal weight” rating in a research report on Friday, September 7th. Nine investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $39.86.
Ceridian HCM stock traded up $0.26 during mid-day trading on Wednesday, reaching $36.34. The company’s stock had a trading volume of 1,137,934 shares, compared to its average volume of 1,304,186. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.43. Ceridian HCM has a 12-month low of $28.65 and a 12-month high of $44.98.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Morgan Stanley lifted its holdings in shares of Ceridian HCM by 250.7% during the 3rd quarter. Morgan Stanley now owns 5,523 shares of the company’s stock worth $232,000 after acquiring an additional 3,948 shares during the last quarter. Voya Investment Management LLC bought a new stake in shares of Ceridian HCM during the 2nd quarter worth $247,000. Public Employees Retirement System of Ohio bought a new stake in shares of Ceridian HCM during the 2nd quarter worth $286,000. Point72 Asset Management L.P. bought a new stake in shares of Ceridian HCM during the 2nd quarter worth $332,000. Finally, Cubist Systematic Strategies LLC bought a new stake in Ceridian HCM in the second quarter worth $344,000. 70.02% of the stock is owned by institutional investors.
In other news, Director Cannae Holdings, Inc. sold 4,396,694 shares of Ceridian HCM stock in a transaction on Friday, November 16th. The shares were sold at an average price of $34.70, for a total transaction of $152,565,281.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Arthur Gitajn sold 135,755 shares of Ceridian HCM stock in a transaction on Tuesday, October 23rd. The stock was sold at an average price of $36.18, for a total transaction of $4,911,615.90. The disclosure for this sale can be found here.
About Ceridian HCM
Ceridian HCM Holding, Inc engages in the provision of human capital management services. It operates through Human Capital Management (HCM), and LifeWorks segments. The Human Capital Management segment includes cloud solutions, dayforce and powerplay, as well as bureau HCM solutions. The LifeWorks segment reflects the results of LifeWorks joint venture.
Recommended Story: Fundamental Analysis
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.